Can-Fite BioPharma Reports Narrower Loss For 9 Months

Can-Fite BioPharma Ltd. (CANF) on Friday reported net loss of $8.49 million for $0.02 per share for the 9-month period ended September 30, 2021, narrower than $11.53 million or $0.04 per share in the same period last year, primarily due to decrease in research and development expenses.

Research and development expenses for the nine months period were $6.75 million compared with $9.06 million for the same period in the prior year.

Revenue for the period was $0.65 million compared with $0.61 million a year ago.

On September 30, 2021, Can-Fite had about $13.3 million in cash, cash equivalents, and short-term deposits.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Oilfield services company Schlumberger Ltd. reported Friday a profit for the fourth quarter that surged 61 percent from last year, reflecting 13 percent higher revenues amid growth across all segments and regions. Both adjusted earnings per share and quarterly revenues topped analysts' estimates. Twitter Inc. has launched a new feature to allow some users of its Blue subscriber service to keep non-fungible tokens or NFTs as their profile pictures. Twitter Blue is now available in the US, Canada, Australia, and New Zealand. NFT is a crypto token, which is non-fungible, meaning that it can neither be transferred like money nor replaced with something else. Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23.
Follow RTT